Canada: At the Forefront of Technology and Life Sciences Practice in Canada and Beyond

Last Updated: November 19 2004

Published in The Metropolitan Corporate Counsel, October 2004.

Editor: Ms. Reicin, would you tell us something about your professional experience?

Reicin: I have been practicing corporate and securities law for over 20 years. My practice has been a general corporate practice focused on securities, financing, mergers and acquisitions and general corporate advice. Fifteen years ago I started getting involved in health technology and other technology competencies, and this has been the core of my practice ever since.

Editor: You are the practice leader of Torys’ technology and life sciences groups. For starters, please tell us how you came to this area.

Reicin: I wrote my economics thesis in 1980 on the emerging Israeli technology sector. This was very modest at the time, but since then Israel has emerged as one of the major technology centers in the world. I then spent a year working with the fledgling Israeli industry. That was a very good experience for me, and I developed a sense of the industry from the inside, which has served me well ever since. When I returned to the United States, I began working on health technology deals, and one deal soon led to another as clients began to recommend my services. Soon enough, I was spending most of my time in this area.

Editor: How did you come to Torys?

Reicin: Torys is known to have one of the best and most extensive technology practices in North America, and a few years ago Canada’s preeminent IP life sciences practice, led by Eileen McMahon and Conor McCourt, joined Torys. That sent a signal to everyone engaged in this area that Torys was determined to make its practice the standard by which other firms measured theirs. It certainly piqued my interest in Torys, and I followed the firm’s fortunes. Torys is unique in that it is a firm that values emerging companies and the entrepreneurial spirit but also has a blue chip institutional client base. Technology clients looking to grow can best be serviced by a firm that can take them from the cradle through growth, including major transactions, mergers and acquisitions and IPOs. However, most law firms with large and substantial clients and experience in sophisticated transactions do not seek entrepreneurial business clients. More importantly, I found I was constantly competing with Torys for new business. It’s now great to be part of the team.

Editor: What advantage does the life sciences sector in Canada offer?

Reicin: Canada is largely an untapped resource in the life sciences area. Yet Toronto is the fifth largest biotech research hub in North America, with a high level of innovation and much lower research costs than in the United States.

Life sciences investors are looking for ways to reduce risk. In my opinion, one of the best ways of reducing risk is to reduce costs. Costs of research in Canada can be, depending on the available tax credits, 30% to 50% less than the cost of doing the same research in the United States. And, with the average cost of bringing a drug to market exceeding $850 million, this amount of reduction – of even a portion – of those costs can be significant. In addition, the research facilities are top flight, as are the people who administer and operate them, and competition for the best investment opportunities is much less.

Our group at Torys is involved in cultivating those opportunities and in aiding with the commercialization and financing of the initiatives that result from them. Because of our cross-border capability, we help Canadian companies structure themselves so that they are attractive not only to Canadian investors, but also to U.S. investors.

Editor: Would you give us an overview of Torys’ life sciences group?

Reicin: At Torys, the life sciences group is a subset of the technology group. The latter has about 40 full-time lawyers, about half of whom have a corporate background; the others are from the IP and health regulatory fields. In addition, there are 15 to 20 lawyers from other disciplines or practice areas who spend a substantial amount of time working in the industry, including tax lawyers, litigators, employee benefits and labor lawyers.

Editor: What types of clients does your practice represent?

Reicin: The companies are U.S., Canadian, European and Israeli. We represent venture capitalists, investment bankers, biotech companies, medical device companies, pharmaceutical companies, nutraceutical companies, and just about any type of enterprise – whether neweconomy or traditional – that is interested in the creation, acquisition, use and commercial exploitation of technology. These organizations run the gamut from start-ups to later-stage and mature enterprises. They seek advice from us in a variety of areas that connect to technology and life sciences, including advice on private and public financings, the protection and commercial exploitation of intellectual property rights, e-commerce and Internet matters, technology contracting, litigation, stockholder and employment matters, international business structures, distribution arrangements, strategic alliances, partnerships and joint ventures, licensing, stock exchange listings, and mergers and acquisitions. In light of our extensive experience in all of these areas, we believe we are in a position to add significant value to the undertakings of these clients. As a measure of the quality of service we provide, I should note that many of these companies come to Torys for strategic planning advice.

Editor: Your group has the ability to draw upon the talents of people from all across the firm?

Reicin: Torys has extraordinary resources, and this is of great importance in serving life sciences companies. They carry on their activities all over the world and need a great many services, including IP advice, health regulatory advice, international tax planning and litigation services. There must be some coordination and prioritization of all these needs, and a firm like Torys – which has attorneys who really understand the industry – is in a position to bring it all together. As I say, this is how Torys adds value, and this is, I think, the way in which it differentiates itself from other firms. That familiarity with the industry and the ability to bring a whole battery of legal disciplines and specialties to bear on an issue constitute the firm’s value proposition.

Editor: A lawyer must have at least some understanding of the client’s business and the principles of the technology that underlie it in order to provide effective advice. To what extent is this a challenge for Torys?

Reicin: Far from being a challenge, this is where we have our edge. Our bench is quite formidable. As I indicated, our group includes approximately 20 IP lawyers. This number includes people with chemistry and biochemistry degrees, and people who have worked in this industry. They understand the industry’s knowledge base – the science and technology – and they are teamed with people like me who have spent years working with these companies on the particular business issues they face as technology enterprises. We are in a position to anticipate our clients’ legal needs and to help them develop strategies rather than respond passively to those needs.

Editor: I gather this is a borderless practice as well. The Toronto people call upon New York, and vice versa?

Reicin: Totally borderless – that’s the beauty. For our clients, this advantage offers less hassle and greater efficiency, not to mention cost savings. Our group offers clients the intimacy and responsiveness of a small firm but, at the same time, draws upon the resources of a firm consisting of more than 330 lawyers located in the key commercial centers of New York and Toronto. Our presence in these locations, with the skill sets and expertise we possess, enables us to serve our clients both nationally and internationally.

Editor: I gather this is an area of the law that is growing at a rapid pace. That is exciting, but there must be challenges at the same time. Can you share your thoughts with us on this?

Reicin: This is a practice area that requires its practitioners to be quick on their feet. The industry is dynamic. New issues are always arising, and we are required to be constantly creative. That’s what I like about it, and I find that my colleagues are also energized by the pace and dynamism of the practice. At the same time, recurring issues allow us to build on our previous experience. This is an area of the law that is new and that has developed its own set of precedents. As we move forward, those precedents provide a basis and framework for our practice.

Editor: What about the future? Where do you see Torys’ life sciences and technology groups in, say, five years?

Reicin: We will continue to dominate the Canadian market and become a substantial player in the U.S. market. As we grow our U.S. practice, our New York office will become our "base" office.

Editor: You combine a very active career as a lecturer and writer with your legal practice. How do these two aspects of your career connect?

Reicin: The two connect very well. In fact, the speaking and writing forces me to think of creative solutions and approaches to client issues. Speaking and writing is as much a learning experience as it is a teaching experience, and as a result I think I am able to bring more to my practice, and to my clients, than if I did not carry on with this activity. Most lawyers are busy with their practices just turning out deals and often don’t get a chance to take a step back and reflect on new structures and other creative ideas. Being proactive and thinking of new model ideas and approaches for my client is where I think I bring the most value.

Editor: Is there anything you would like to add?

Reicin: I enjoy working in a firm whose lawyers are totally dedicated to their clients. The compensation structure and team-oriented atmosphere are such that people want to work together, ensuring that the best resources and most appropriate people are put on each project. Not only is this a great way to practice law, it provides the best service to the clients. Our attorneys are focused on practicing law rather than internal politicking

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions